SCHEMBL2881115

SCHEMBL2881115

CC(C)COC(=O)N1CCC(COc2ccc(-c3ccc(S(C)(=O)=O)cc3)c(F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 16/20 0.52
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881370 0.95 GPR119 (0.51) GPR119
SCHEMBL3844161 0.88 GPR119 (0.55) GPR119CHRM2CHRM1
SCHEMBL387485 0.86 GPR119 (0.61) GPR119
SCHEMBL2881163 0.85 GPR119 (0.52) GPR119
SCHEMBL2879359 0.84 GPR119 (0.52) GPR119
SCHEMBL384974 0.84 GPR119 (0.63) GPR119
SCHEMBL2881232 0.82 GPR119 (0.61) GPR119
SCHEMBL2881337 0.82 GPR119 (0.56) GPR119CHRM2CHRM1
SCHEMBL2881607 0.80 GPR119 (0.58) GPR119
SCHEMBL388406 0.80 GPR119 (0.66) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010512334-A 2010-04-22 JP claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP claimed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO claimed